News
MHRA issues precautionary Class 3 recall for Cyclizine Lactate injection
Healthcare professionals must immediately quarantine affected stock over manufacturing deficiencies, while patient risk remains low
Jun 16, 2026
This Site is Intended for Healthcare Professionals Only